GENERAL MILLS INC (GIS): what the price requires

The current priced-in claim for GENERAL MILLS INC (GIS) is temporarily suppressed because the live engine record is unavailable. The dated report remains a snapshot, not a current market read.

Generated: 2026-07-14 · Exported: 2026-07-17 · Source: https://boothcheck.com/report/GIS

Headline

FieldValue
TickerGIS
CompanyGENERAL MILLS INC
Current price$36.70/sh

What The Price Requires (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin today21.1%
Multiple paid8x operating income

The price sits below what even a 5%/yr operating-profit decline would warrant; the inversion reports a bound, not a solved growth path.

Solve inputs: computed at a 6% cost of capital with 4% terminal growth over a 5-year stage (computed at the 6% minimum rate; the CAPM rate 5.8% sits below it).

How unusual the bet is: within-range

ReferenceValue
vs own history-1.12σ
cohort percentile (of 69 peers)4
implied end-window share0%

Valuation X-Ray

The price is supported by earnings-power and relative-multiple value. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset1.37x5expensive
Earnings1.14x4expensive
Relative0.54x3justifies
Growth1.31x4expensive

Families that justify the price: Earnings, Relative

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 9.4%); the inversion above states its own rate.

Per-Model Detail (n=16)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$27.841.32xyesFCF base $1.7B, growth -6% (input: historical growth), terminal g 0.5%, WACC 9.4%, 5yr projection
DCF Exit MultipleGrowth$37.580.98xyesExit EV/EBITDA: 4.0x / 5.5x / 7.5x (bear / base = today's held flat / bull), 5yr
Relative ValuationRelative$59.210.62xyesP/E 22x (static sector reference · 2026-04), scenarios: 18.7x / 22.0x / 25.3x (bear / base = reference held flat / bull), EV/EBITDA 10.58x
Simple DDMGrowth——no—
Two-Stage DDMGrowth$28.231.30xyesStage 1: -6% for 5yr, Stage 2: 3.5% perpetual
Simple Excess ReturnAsset$23.341.57xyesBV/sh $17.39, ROE (TTM) 12.4%, ke 9.3%
Two-Stage Excess ReturnAsset$26.851.37xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$18.801.95xyesRev $18.4B, growth -6% (input: historical growth; tapered), Terminal P/S: 0.9x / 1.1x / 1.2x (bear / base = today's held flat / bull, cap 8x)
Growth-Adjusted P/ERelative——no—
Margin TrajectoryGrowth——no—
Earnings Power ValueEarnings$56.620.65xyesNormalized EBIT (5y avg op income, one-time charges added back) $3.61B × (1−21%) / WACC 9.4% → EPV (no growth)
Residual IncomeAsset$27.571.33xyesBV $17.39 + 5yr PV of (ROE (TTM) 12.4% − Kₑ 9.3%) × BV; BV grows 8.1%/yr
Graham NumberAsset$28.981.27xyes√(22.5 × EPS $2.15 × BVPS $17.39) — Graham's conservative floor
EV/EBITDA RelativeRelative$94.260.39xyesEBITDA $3.62B × sector EV/EBITDA 14.0x
FCF YieldEarnings$33.101.11xyesFCF $1650.1M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarnings$31.291.17xyesSBC-adj FCF $1.56B (FCF $1.65B − SBC $0.09B) capitalized at Kₑ
Ben Graham FormulaEarnings$1.8020.39xyesEPS $2.15 × (8.5 + 2×-5.0%) × (4.4 / 5.3%) (excluded from median)
ROIC-Justified P/BAsset$8.194.48xyesBV $17.39 × (ROIC 4.4% / WACC 9.4%)
P/Sales SectorRelative$68.380.54xyesRevenue $18.37B × sector P/S 2.0x
PEG Fair ValueRelative——no—
Earnings YieldEarnings$23.201.58xyesEPS $2.15 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelative——no—
Clinical Phase NPVGrowth——no—
MertonAsset——no—
V5 Mechanical———no—

Solvency

FieldValue
Net debt$12.3b
Net debt / NOPAT (after-tax)4.04x
Net debt / operating income (pre-tax)3.19x
Interest coverage7.4x
Share count CAGR (buyback)-3.2%
Burning cashno

Bullet Takeaways

General Mills' moat is brand shelf space and scale in packaged food, and it shows up as a 19% trailing operating margin. That durable profitability is what makes a deep-value price look like a mispricing rather than a warning.

At $33.42 the market pays only about 8 times operating income, below what even a 5%-a-year operating-profit decline would warrant. Every valuation family supports the price; this is a value name, not a growth bet.

The offset is leverage and a soft top line. Net debt sits near $12.3 billion, and organic sales are guided roughly flat for fiscal 2026. The Q4 and full-year report on July 1, 2026 is the near-term catalyst that tests whether the Remarkability playbook is reviving volume.

Bull Case

General Mills' competitive position rests on something boring and durable: owning shelf space. Across cereal, snacks, baking, and a large North America pet-food business, the company holds category-leading brands that retailers must stock and consumers reach for by habit. That structural advantage shows up where it matters, in a 19% trailing operating margin, the kind of profitability that signals real pricing power rather than commodity economics. The FY2025 10-K lays out the breadth: a North America Retail segment spanning "shelf-stable vegetables, meal kits, fruit snacks and snack bars" (FY2025 10-K, accession 0001193125-25-147079) alongside a North America Pet segment selling "pet food products sold primarily in the United States and Canada in national pet superstore chains" (accession 0001193125-25-147079). A diversified portfolio of branded staples is exactly the kind of business that holds margin through cycles, and the margin data confirms the moat is intact.

The valuation is where the moat becomes an opportunity. At about 8 times operating income, the price sits below what even a 5%-a-year decline in operating profit would warrant. The market is treating a profitable, cash-generative consumer-staples leader as if its earnings are about to fall meaningfully. The model lenses disagree across the board: earnings-power value lands near $57, relative valuation near $59, and the EV/EBITDA-relative frame near $94, all far above the $33.42 (June 27, 2026) quote. When a wide-margin staples business trades at a multiple that implies erosion, the bull case does not need growth, it needs the brands to keep doing what they have done for decades.

The company is also actively defending the franchise and returning cash. Management's Remarkability playbook is investing to improve brand relevance, and the company points to gains in household penetration, baseline volume, distribution, and market share across core businesses. The share count has been shrinking by roughly 3% a year, so each remaining share owns more of the portfolio over time, and the dividend is a long-standing feature of the staples profile. Against the food-and-beverage peer set of Kraft Heinz, Hormel, Mondelez, McCormick, and Hershey, General Mills offers a combination of category leadership, high margin, an undemanding multiple, and disciplined capital return. The price assumes decline; the moat and the capital-return engine argue for durability.

Bear Case

The structural weakness in General Mills is the balance sheet, and it constrains the company precisely when the business needs flexibility. Net debt sits near $12.3 billion against roughly $3.5 billion of trailing operating income, putting net debt to operating income above 3.5 times, with interest covered about 6.6 times. That is a meaningful debt load for a business whose top line is barely growing. Leverage at this level limits how aggressively the company can invest in brand revitalization, pursue acquisitions, or buy back stock, and it raises the stakes on every refinancing as rates move. A staples company is supposed to be a fortress; here the fortress carries a mortgage that eats into the cash available to defend the brands.

The second problem is that the cheap multiple may be cheap for a real reason: the top line is stagnant. The company guides fiscal 2026 organic net sales to a range of down 1% to up 1%, with inorganic items reducing reported growth by about 4%. Flat-to-declining organic sales in packaged food reflect structural headwinds, private-label competition, shifting consumer preferences toward fresh and away from center-store packaged goods, and the pressure of GLP-1 weight-loss drugs on snacking and cereal volumes. The market's decline-implying multiple is not irrational; it is pricing a business that is struggling to grow volume in categories under secular pressure. A value multiple on a structurally challenged top line can stay cheap indefinitely if the volume erosion continues.

The third issue is that the moat, while real, is being tested at the edges. Retailer private-label brands have improved in quality and gained share, the pet-food business faces its own competitive and demand pressures, and the company's pricing power, the source of the 19% margin, is harder to exercise when consumers are trading down. The Remarkability playbook is an admission that brand relevance needed reinvestment, and reinvestment costs margin. The bull case rests on durability, but durability in staples is not permanence: categories decline, habits change, and a leveraged balance sheet leaves less room to adapt. A holder is betting that a high-margin but slow-growing, debt-laden staples company holds its earnings while paying down debt and reviving volume. That can work as a value-and-yield holding, but it is not a growth story, and the price reflects a market that doubts even the flat-line.

Valuation

The inversion points firmly toward value. At $33.42 the market is paying only about 8 times company-wide operating income, a multiple so low the price sits below what even a 5%-a-year decline in operating profit would warrant. This is a bound, not a precise solve: the price is consistent with the market expecting earnings to fall rather than implying any particular growth rate. The priced-in assumption reads as within range, and the near-term pace is within what the company has recently delivered, so the market is pricing pessimism into a profitable staples business.

The model X-ray is unusually unanimous: this is a value and asset-supported name where no family flags the price as expensive. Asset-based frames bracket or exceed the price (residual income near $28, two-stage excess return near $27, simple excess return near $23). Earnings-power frames land at or above it (earnings-power value near $57, FCF yield near $33). Relative-multiple methods land far above (relative valuation near $59, EV/EBITDA relative near $94, P/sales sector near $68). Growth-DCF frames cluster near the quote (DCF perpetual growth near $28, two-stage DDM near $28). The blended cross-method anchor sits near $28, close to the price. When asset, earnings, relative, and growth lenses all support or exceed the quote, the read is a genuinely cheap stock rather than a value trap by the methods alone.

The balance sheet is the caveat that keeps this from being a slam-dunk. Net debt of about $12.3 billion against roughly $3.5 billion of operating income puts leverage above 3.5 times, with interest coverage around 6.6 times, serviceable but a constraint on flexibility. The flat organic-sales guidance for fiscal 2026 is the real risk: cheap is only an opportunity if earnings hold. The recent strategic focus on the Remarkability playbook and reported gains in household penetration and market share are supportive but unproven at the revenue line. The reasonable conclusion is that General Mills is a high-margin, category-leading staples company trading at a decline-implying multiple, where the upside is the brands holding their earnings and the downside is continued volume erosion against a leveraged balance sheet. It is a value-and-income bet on durability, with the next earnings report the live test.

Catalysts

The most important near-term catalyst is the fiscal 2026 fourth-quarter and full-year earnings report, scheduled for July 1, 2026. Management has signaled it expects Q4 to show a meaningful step-up in top-line and bottom-line performance, with the midpoint of guidance implying about 75 to 80 basis points of organic sales growth in the quarter and the Pet segment expected to be roughly neutral. For the full year, the company guides organic net sales to a range of down 1% to up 1%, with inorganic items reducing reported net sales growth by about 4%. (Sources: General Mills 8-K and investor releases; GuruFocus; Barchart Q4 preview.)

The central forward question is whether the Remarkability playbook is reviving volume. Management points to improving household penetration, baseline volume, distribution, and market share across core businesses, and the July 1 report is the test of whether those investments are translating into organic growth. The signals to watch are organic sales by segment (especially North America Retail and Pet), volume versus pricing mix, and progress on debt reduction against the roughly $12.3 billion net debt load. Because the stock is priced for decline, evidence of stabilizing or improving organic sales would be the clearest upside catalyst, while continued volume erosion would validate the cheap multiple. (Sources: General Mills businesswire release; Simply Wall St; TipRanks earnings.)

Peer Cohorts (Per Segment, With Filing Citations)

North America Retail (reported)

North America Pet (reported)

North America Foodservice (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

View the full interactive GIS report on boothcheck